STEPHAN DIETRICH A (President and CEO) purchased 12.5% of their position (1.25K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/26/2020ACC: 0001104659-20-065897
DirectorOfficer· President and CEO
Since Jul 2019
+1.25K
Net shares
Net buyer
$10.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.25K
Price / share
$8.09
Trade value
$10.11K
% of position
12.5%
5/21/2020
10K→11.25K
Total
Net shares
+1.25K
Net value
$10.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2020 | P · Purchase | +1.25K | $8.09 | $10.11K | 12.5% | 10K | 11.25K |
| Total | +1.25K | $10.11K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.55M
Total
2.55M indirect2.55M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.55M | Indirect |
| Total | 2.55M | 2.55M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported